BRDT is a novel regulator of eIF4EBP1 in renal cell carcinoma

Among all types of kidney diseases, renal cell carcinoma (RCC) has the highest mortality, recurrence and metastasis rates, which results in high numbers of tumor-associated mortalities in China. Identifying a novel therapeutic target has attracted increasing attention. Bromodomain and extraterminal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Pei, Chen, Zhilin, Zhong, Weifeng, Jiang, Huiming, Huang, Zhicheng, Peng, Dong, He, Qiang, Chen, Nanhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610328/
https://www.ncbi.nlm.nih.gov/pubmed/33125143
http://dx.doi.org/10.3892/or.2020.7796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610328/
https://www.ncbi.nlm.nih.gov/pubmed/33125143
http://dx.doi.org/10.3892/or.2020.7796

Ejemplares similares